Cladribine nucleotide pools are diminished in resistant myeloma cell fines, as compared to sensitive lymphoma cell lines.

被引：0
|
作者：
Hoffman, MA [1 ]
Xu, JC [1 ]
Rai, KR [1 ]
机构：
[1] LONG ISL JEWISH MED CTR,NEW HYDE PK,NY 11042
来源：
BLOOD | 1997年 / 90卷 / 10期
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：3640 / 3640
页数：1
相关论文
共 50 条
  • [1] Expression of deoxycytidine kinase (dCK) is reduced in cladribine resistant cell lines compared to cladribine sensitive cell lines.
    Hoffman, M
    Xu, JC
    Wei, LX
    Rai, KR
    BLOOD, 1998, 92 (10) : 193B - 193B
  • [2] PKC δ inhibition induces cell death in thalidomide and dexamethasone resistant multiple myeloma cell lines.
    Bahlis, NJ
    Sawney, R
    Gerson, S
    BLOOD, 2002, 100 (11) : 393A - 393A
  • [3] STI 571 inhibits c-kit phosphorylation and is cytotoxic to drug sensitive and resistant myeloma cell lines.
    Suciu, I
    Shain, KH
    Mackley, PA
    Gerbino, E
    Dalton, WS
    Alsina, M
    BLOOD, 2002, 100 (11) : 169A - 170A
  • [4] Simvastatin induces death of multiple myeloma cell lines.
    Drucker, L
    Gronich, N
    Radnay, J
    Shapira, H
    Lishner, M
    BLOOD, 2002, 100 (11) : 366B - 367B
  • [5] Heterogeneity of cytokine: Production in cloned myeloma cell lines.
    Campbell, JDM
    Carr, CE
    Cook, G
    Franklin, IM
    EXPERIMENTAL HEMATOLOGY, 1998, 26 (08) : 791 - 791
  • [6] False leukemia-lymphoma cell lines: An update an over 500 cell lines.
    Drexler, HG
    Dirks, W
    Matsuo, Y
    MacLeod, RAF
    BLOOD, 2002, 100 (11) : 330A - 330A
  • [7] Raman spectroscopy differentiates between sensitive and resistant multiple myeloma cell lines
    Franco, Domenico
    Trusso, Sebastiano
    Fazio, Enza
    Allegra, Alessandro
    Musolino, Caterina
    Speciale, Antonio
    Cimino, Francesco
    Saija, Antonella
    Neri, Fortunato
    Nicolo, Marco S.
    Guglielmino, Salvatore P. P.
    SPECTROCHIMICA ACTA PART A-MOLECULAR AND BIOMOLECULAR SPECTROSCOPY, 2017, 187 : 15 - 22
  • [8] Gene expression profiling of T-cell lymphoma cell lines.
    Fillmore, CG
    Lin, ZS
    Bohling, SD
    Robetorye, RS
    Jenson, SD
    Elenitoba-Johnson, KSJ
    Lim, MS
    BLOOD, 2001, 98 (11) : 158B - 158B
  • [9] Screening for drug activity in resistant cancer cell lines.
    Rickardson, L
    Haglund, C
    Fryknäs, M
    Lövborg, H
    Nygren, P
    Gustafsson, MG
    Isaksson, A
    Larsson, R
    CLINICAL CANCER RESEARCH, 2005, 11 (24) : 8987S - 8987S
  • [10] Rapamycin-resistant human lymphoid cell lines.
    Kay, JE
    Wellhausen, A
    Frost, V
    Morgan, GY
    Smith, MC
    Morley, SJ
    BIOCHEMICAL SOCIETY TRANSACTIONS, 1996, 24 (01) : S89 - S89
12345